The last several years have witnessed the explosive growth of transradial catheterization and intervention internationally and in the United States. Emerging data have supported the differential value of this technique in enhancing patient safety, mobility, comfort and reducing healthcare delivery costs.
Although global healthcare trends are driving increased adoption of transradial access, it remains underutilized in the United States. Thesefindings highlights the need to provide high-quality, practical physician and nurse/tech education and training in transradial access to a large number of providers, as currently only ~20% of coronary procedures in the United States are performed transradially.
PAMEAS has produced over twenty Transradial Summit programs since 2009. Each one provides practical, straightforward content requisite for establishing or expanding a successful transradial practice. Through the use of targeted presentations, high-definition case video, and interactive discussions with our expert faculty, attendees gain valuable insights into improving their transradial technique, approaching complex patient subsets, and technical problem solving.
Our Transradial Summit theme is "Radial First Catheterization" and will focus on bringing our audience valuable content whether you are new to or experienced in transradial access. Topics that will be covered include clinical instruction on transradial technique, transradial applications in the periphery, devices with transradial application, management of transradial complications, transradial case reviews, cost benefits of transradial and same-day discharge, and topics for nurses/techs/managers.
It is the goal of the Patient Medical Association to encourage a "Radial First" policy and to have transradial access increase in utilization to 50% of all diagnostic and interventional endovascular procedures in the United States by 2020. Since PAMEAS began its transradial training programs in 2005, thousands of physicians, nurses, and staff have attended Transradial Summit conferences, dinner programs, grand rounds, preceptorships, and proctorships.
Transradial Vascular Access affords the following advantages over transfemoral access:
- Reduced access site complications
- Earlier mobility of patients
- Reduced intensity of post-procedure care
- Reduced length of hospital stay
- Expedited throughput in the cath lab
- Enables outpatient PCI
- Earlier return to productivity for patients
- Reduced cost of vascular closure devices Increased comfort for patients
With changes in CMS guidelines, there will also likely greater revenue for hospitals and physicians that provide a transradial option to their patients.
The results of the RIVAL Trial (A randomized comparison of RadIal Vs. femorAL access for coronary intervention in acute coronary syndromes) were presented at the American College of Cardiology (ACC) 60th Annual Scientific Sessions on April 4, 2011. Among the findings were that patients who undergo diagnostic or interventional endovascular procedures have similar probability of survival whether their radial or femoral artery is used for access. However, when patients are suffering from an acute coronary syndrome such as an ST elevation myocardial infarction (STEMI), there is significant survival benefit if the coronary arteries are accessed via the radial artery.
RIVAL is the first large North American randomized clinical trial comparing the two artery access options. The findings are likely to increase utilization of transradial access in the United States because:
Radial access has now been shown to be a safe and effective technique in patients.
ACS patients have a significant survival benefit when they were treated transradially.
Radial access is preferred by patients.
This program is designed to provide the greatest educational value to the practicing interventional cardiologist, radiologist, or vascular surgeon with interest and/or experience in adoption of transradial technique. Fellows, residents, nurses, and techs will also find value in attending the program.
After attending a transradial summit program, the participant should be able to:
- Discuss strategies for patient selection for transradial access
- Describe pharmacotherapy associated with transradial access
- Discuss catheter selection for angiography & PCI using transradial access
- Describe post-procedural care and complications
- Describe the logistics of starting a transradial practice
- Demonstrate techniques for transradial access
As with all PAMEAS programs, the directors and organizers of Transradial Summit programs are committed to producing the finest, most practical transradial education and training available anywhere for little or no cost to our program attendees. We are able to do this because of the support provided by our industry partners and other educational grants received by PAMEAS to improve patient care through healthcare provider education.
PAMEAS Transradial Summit programs are being funded, in part, by educational grants from various commercial supporters. The Patient Medical Association gratefully acknowledges the assistance provided by our commercial supporters and appreciates their ongoing commitment to physician education. If you are interested in supporting Transradial Summit programs, please email firstname.lastname@example.org or call 888.508.8554.
Commercial support from industry does not influence educational content, faculty selection, and/or product usage during demonstrations and, therefore, does not compromise the scientific integrity of Transradial Summit programs. The decision to discuss off-label product usage and/or off-label product use during demonstrations is made at the sole discretion of the faculty. Off-label product usage is not endorsed by PAMEAS, or our co-sponsors, or our commercial supporters.
It is the policy of the Patient Medical Association to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All faculty participating in any PAMEAS-sponsored programs must disclose, in advance, any relationship with commercial interests. The disclosure information and nature of the relationship(s) provided by each faculty member is available to all PAMEAS course attendees upon request.
Each Transradial Summit will provide attendees a workshop during which they can experience hands-on sessions with the most advanced transradial simulation technology from Mentice and the most advanced transradial-related medical device technology from our commercial supporters.
Mentice is a world leader in medical simulation providing qualified solutions for training, education and assessment opportunities. With a focus on minimally invasive techniques and procedures, Mentice develops simulation systems for training in a safe environment within thefields of endovascular intervention and minimally invasive surgery.
|7:00 a.m.||Continental Breakfast & Welcome|
|8:00 a.m.||Transradial Room Setup, Patient Preparation, and Radial Access|
|9:00 a.m.||Vascular Anatomy of the Arm and Advancement of Catheters into the Aorta|
|9:30 a.m.||Transradial Guide Catheter Selection & Manipulation: Optimizing Engagement and Support|
|10:00 a.m.||Live Transradial Simulation Case Demonstrations|
|10:45 a.m.||Hemostasis and Avoidance, Recognition, and Management of Radial Complications|
|11:30 a.m.||Advanced Transradial Topics (Peripheral Interventions, Transradial & Coumadin, Right Heart Studies, Left Arm/Ulnar Access, ACS & Transradial)|
|12:15 p.m.||Lunch presentation: Optimizing Femoral Access|
|1:30 p.m.||Starting a “Radial First” Program: Start-Up Costs, Staff Education, Patient Education, Hurdles, Marketing|
|3:00 p.m.||Complex Transradial Case Review, Hands-on Transradial Simulator Experience, PAMEAS Technology Fair|
|5:00 p.m.||Program Conclusion|